Author Guidelines

Contributions submitted to the Revista Chilena de Infectología (RCI) must comply with the journal's editorial line. Manuscript topics include relevant areas for Latin American Infectology such as general clinical infectology, pediatric infectology, clinical microbiology, parasitology, vaccines, and epidemiology.

A. Article Typology:

• Editorial
• Research Articles
• Review Articles
• Clinical Experiences
• Point of View
• Documents/Academia
• Clinical Guidelines
• Clinical Cases
• Brief Communications
• Letters to the Editor
• Distinction/Tribute/In Memoriam
• Microbiological Portrait
• Historical Note

B. Language: Original articles (research articles, review articles, clinical experiences, point of view, clinical guidelines, and documents) must be submitted in Spanish and English. Clinical cases, brief communications, letters to the editor, microbiological portrait, and historical note must be submitted in Spanish.

C. Manuscript Submission: Articles must be entered directly by their authors into the RCI electronic platform following the submission link (https://revinf.cl/index.php/revinf/submissions).

D. Mandatory Submission Requirements: Submitted contributions must comply with all the points listed below. Failure to do so will result in the rejection of the submission:

1. Title in Spanish.
2. Title in English.
3. Name of the authors.
4. Signature of each author.
5. Declaration of authorship responsibility (specifying each person's contribution to the manuscript; see the Authorship section).
6. Affiliation of each author.
7. Name of the corresponding author.
8. Email of the corresponding author.
9. Declaration of conflicts of interest.
10. Funding declaration.
11. Ethics Committee Certification (see the Ethics section).
12. Abstract in Spanish and English (with entirely similar content to the Spanish version). Maximum of 200 words.
13. Keywords in Spanish and English (3 to 6) separated by ";", preferably using PubMed MeSH Terms.
14. Main text.
15. Bibliographic references: DOIs for each reference must be included. If not available in PubMed, indicate the corresponding PMID; in all other cases, indicate the web address where the text is available.
16. Complete Metadata (on the editorial platform): complete for the author and each co-author, including name, email, and, optionally, the ORCID of each author.

E. Authorship:

• The first author is considered to be the one who made the most significant contribution to the manuscript, including design, data collection and analysis, design of tables, figures, and graphs, bibliographic search, discussion, and final review of the text submitted to RCI.
• An author is considered to be someone who has actively participated in the research in addition to drafting the submitted manuscript.
• Those who have made a relevant contribution to the development of the research (such as providing data, correcting the academic style of the article, among others) may be listed in the Acknowledgments of the article.

For the above reasons, each author must indicate in which of the following points they have participated, noting their contribution to the manuscript:

1. Conception/design of the work
2. Data/information collection
3. Data analysis/discussion
4. Bibliographic review
5. Manuscript preparation
6. Review of the final version

F. Ethics: For research articles involving human beings or animals, a copy of the authorization certificate from an accredited Ethics Committee is required. For clinical cases, a copy of the informed consent in which the patient or their legal guardians authorize the publication of clinical data and images is required.

G. Declaration of Conflict of Interest: This must be made explicit for all articles published in the journal, by each of the authors.

H. Funding Declaration: If the research received support from a competitive funding source (e.g., in Chile, Fondecyt, administered by the National Agency for Research and Development - ANID), it must include the agency, the exact name of the grant, and the official code or folio of the project assigned in the agreement.

I. Editorial Process Deadlines: Once the article and attached documents are submitted to the platform, the editors have a maximum period of three weeks to verify that the manuscript meets all formal requirements and decide whether it is accepted for peer review or rejected (which will be notified by the platform). The stipulated time for reviewers is one month; however, exceptionally, this period could be extended due to delays by the evaluators or the arbitration process. Once the first round of review is completed, authors must submit a revised version with corrections within a maximum period of 28 days, along with an attached letter responding point by point to the reviewers' comments. After this period, the article is withdrawn from the editorial process. If there are force majeure reasons for not meeting this deadline, the author must send a letter through the platform requesting an extension.

J. Formal Manuscript Requirements: Word file, font size 12, double-spaced, and justified.

K. Bibliographic References: Must be incorporated according to Index Medicus/MEDLINE conventions, Vancouver style (https://www.icmje.org/). Number the references (Arabic numerals) in the order they are first mentioned in the text. DOIs for each reference must be included when available.

1. For journals: Author(s) last name and initial of first name. Mention a maximum of six authors; if more, add "et al". Full title in its original language. Journal name abbreviated according to Index Medicus, year of publication; journal volume, initial and final page of the article.
2. For books/texts: Last name and initial of the author(s) of the chapter, title of the chapter, last names and initials of the editor(s), name of the book, city and country, publisher, year, initial and final page.
3. For electronic articles: Indicate the website where the citation was obtained (preceded by "available at") and the date of access.

L. Tables and Figures: Must include a title and an explanatory legend. They will be numbered sequentially (Arabic numerals), strictly following their order of appearance in the text. The numbering of tables and figures will be done independently. Any abbreviation or symbol used must be explained in a legend below each table or figure. In the reproduction of microscopic preparations, the magnification and staining methods must be mentioned.

M. Artificial Intelligence: All authors of research articles, brief communications, review articles, and clinical cases must declare if any artificial intelligence tool has been used, either in the preparation of the writing or in the research itself. The responsibility for the content of an article lies entirely with the authors, regardless of the use of AI.

Authors must declare the use of AI:

• If AI was used in the preparation of the manuscript (drafting or reviewing).
• If AI was used in the design, execution and/or analysis of the research, or generation of conclusions. A description of how it was used to generate or modify the experimental design, the analysis of the results, and/or the conclusions must be included (declare in the "Methods" section).
• If AI was used in the preparation of the figures, include a description of how it was used to generate or modify the content presented as part of the research (declare in the "Methods" section).

Format for declaring the use of AI:

"[Name of the AI, version, and model of the tool] was used to [list the process(es) for which the AI was used and describe the reason for its use]."

As part of the pre-publication editorial process, authors may be asked to detail the methodology of application of AI tools, in case this information is not specified in the manuscript. The final decision on the acceptance and publication of articles that have incorporated the use of AI will correspond exclusively to the criteria of the editorial committee.

Requirements by Article Type

Clinical Studies / Research Articles

• Structure (text and abstract): Introduction, Objectives, Methods, Results, Discussion, Conclusions and References, Figures/Tables, Figure/Table Legends. Acknowledgments (optional).
• Maximum length: 3,000 words, 7 tables and/or figures, up to 60 references.
• Mandatory attached documents: Letter of Approval by Institutional Ethics Committee, Declaration of Conflicts of Interest, Funding Declaration.

Review Articles

• Authors: Maximum of 5 authors.
• Maximum length: 3,000 words, 5 tables and/or figures, and 60 references.

Clinical Experience

• Structure (text and abstract): Introduction, Objectives, Material and Methods, Results, Discussion, and Conclusions.
• Maximum length: 3,000 words, 5 tables and/or figures, and 60 references.
• Mandatory attached documents: Letter of Approval by Institutional Ethics Committee, Declaration of Conflicts of Interest, Funding Declaration.

Clinical Cases

• Authors: Maximum of 5 authors.
• Maximum length: 2,000 words, 3 tables and/or figures, up to 20 references.
• Mandatory attached documents: Informed consent with authorization from the patient or legal representative to publish clinical data or images of the patient.

Brief Communication

• Authors: Maximum of 5 authors.
• Maximum length: 1,500 words, 3 tables and/or figures, up to 20 references. May include one table and one graph.
• Mandatory attached documents (if clinical research): Letter of Approval by Institutional Ethics Committee, Declaration of Conflicts of Interest, Funding Declaration.

Documents

• Official documents of the Chilean Society of Infectology.
• Documents from other Chilean or foreign academic entities.
• Documents issued by the Chilean Ministry of Health.

Letter to the Editor

• Maximum length: Up to 1,000 words, 2 tables and/or figures, up to 6 references.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party. Only the corresponding author's email will be published in each article.